Indivior Pharmaceuticals, Inc. (INDV)
32.53
-0.44
(-1.33%)
USD |
NASDAQ |
Apr 15, 16:00
32.53
0.00 (0.00%)
After-Hours: 18:29
Indivior Pharmaceuticals Research and Development Expense (Annual) : 80.00M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| ANI Pharmaceuticals, Inc. | 51.66M |
| Catalyst Pharmaceuticals, Inc. | 12.71M |
| Liquidia Corp. | 38.45M |
| Pulse Biosciences, Inc. | 44.72M |
| Ultragenyx Pharmaceutical, Inc. | 723.00M |